Cargando…
Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year
Healthcare workers (HCWs) are playing a vital role in the current SARS-CoV-2 pandemic. This study investigated how infection spreads within three local hospitals and an associated fire brigade in Germany by testing employees for the presence of SARS-CoV-2 IgG antibodies over one year. The three obse...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878380/ https://www.ncbi.nlm.nih.gov/pubmed/35206589 http://dx.doi.org/10.3390/ijerph19042402 |
_version_ | 1784658647272390656 |
---|---|
author | Hildebrandt, Anke Hökelekli, Oktay Uflacker, Lutz Rudolf, Henrik Paulussen, Michael Gatermann, Sören G. |
author_facet | Hildebrandt, Anke Hökelekli, Oktay Uflacker, Lutz Rudolf, Henrik Paulussen, Michael Gatermann, Sören G. |
author_sort | Hildebrandt, Anke |
collection | PubMed |
description | Healthcare workers (HCWs) are playing a vital role in the current SARS-CoV-2 pandemic. This study investigated how infection spreads within three local hospitals and an associated fire brigade in Germany by testing employees for the presence of SARS-CoV-2 IgG antibodies over one year. The three observational periods corresponded to the initial three pandemic waves: first wave: June–September 2020, second wave: October 2020–January 2021, and third wave: February–June 2021. We analysed 3285 serum samples of 1842 employees, which represents 65.7% of all employees. Altogether, 13.2% employees were seropositive: 194/1411 HCWs (13.7%) and 49/431 non-HCWs (11.4%) with a clear increase of seroprevalence from the first (1.1%) to the second (13.2%) and third (29.3%) pandemic wave. HCWs presumably had an additional occupational risk for infection in the second and third wave due to an increase of infection pressure with more COVID-19 patients treated, showing possible weak points in the recommended infection prevention strategy. |
format | Online Article Text |
id | pubmed-8878380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88783802022-02-26 Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year Hildebrandt, Anke Hökelekli, Oktay Uflacker, Lutz Rudolf, Henrik Paulussen, Michael Gatermann, Sören G. Int J Environ Res Public Health Article Healthcare workers (HCWs) are playing a vital role in the current SARS-CoV-2 pandemic. This study investigated how infection spreads within three local hospitals and an associated fire brigade in Germany by testing employees for the presence of SARS-CoV-2 IgG antibodies over one year. The three observational periods corresponded to the initial three pandemic waves: first wave: June–September 2020, second wave: October 2020–January 2021, and third wave: February–June 2021. We analysed 3285 serum samples of 1842 employees, which represents 65.7% of all employees. Altogether, 13.2% employees were seropositive: 194/1411 HCWs (13.7%) and 49/431 non-HCWs (11.4%) with a clear increase of seroprevalence from the first (1.1%) to the second (13.2%) and third (29.3%) pandemic wave. HCWs presumably had an additional occupational risk for infection in the second and third wave due to an increase of infection pressure with more COVID-19 patients treated, showing possible weak points in the recommended infection prevention strategy. MDPI 2022-02-19 /pmc/articles/PMC8878380/ /pubmed/35206589 http://dx.doi.org/10.3390/ijerph19042402 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hildebrandt, Anke Hökelekli, Oktay Uflacker, Lutz Rudolf, Henrik Paulussen, Michael Gatermann, Sören G. Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year |
title | Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year |
title_full | Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year |
title_fullStr | Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year |
title_full_unstemmed | Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year |
title_short | Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year |
title_sort | seroprevalence of sars-cov-2 antibodies in employees of three hospitals of a secondary care hospital network in germany and an associated fire brigade: results of a repeated cross-sectional surveillance study over 1 year |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878380/ https://www.ncbi.nlm.nih.gov/pubmed/35206589 http://dx.doi.org/10.3390/ijerph19042402 |
work_keys_str_mv | AT hildebrandtanke seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year AT hokeleklioktay seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year AT uflackerlutz seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year AT rudolfhenrik seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year AT paulussenmichael seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year AT gatermannsoreng seroprevalenceofsarscov2antibodiesinemployeesofthreehospitalsofasecondarycarehospitalnetworkingermanyandanassociatedfirebrigaderesultsofarepeatedcrosssectionalsurveillancestudyover1year |